Clinical Development of Immunotherapy in Urothelial Cancer
Presented By: Scot Niglio, MD
Speaker Biography: Dr. Scot Niglio graduated from Villanova University with a Bachelor of Science in biology where he was inducted into the Phi Beta Kappa Honor Society and went on to receive a Master of Science in physiology from Georgetown University. He then earned a Master of Science in clinical and translational science at the University of Medicine and Dentistry of New Jersey (now Rutgers University) in combination with his medical degree.
Webinar: Clinical Development of Immunotherapy in Urothelial Cancer
Webinar Abstract: Platinum-based chemotherapy has been the cornerstone for treating metastatic urothelial cancer, which compromises the majority of bladder cancer. While urothelial cancer is chemosensitive, patients often do not have a durable response and ultimately progress. Until recently patients were left with less effective second line chemotherapy options, but this has changed with the advent of immunotherapy.
Earn PACE Credits:
1. Make sure you're a registered member of LabRoots (www.labroots.com)
2. Watch the webinar on YouTube or on the LabRoots Website (https://www.labroots.com/virtu....al-event/immuno-onco
3. Click Here to get your PACE credits (Expiration date 06/03/2022): https://www.labroots.com/credi....t/race-credits/4001/
LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc
-
Category
No comments found